ES2161361T3 - N-oxidos como agentes antibacterianos. - Google Patents

N-oxidos como agentes antibacterianos.

Info

Publication number
ES2161361T3
ES2161361T3 ES96916138T ES96916138T ES2161361T3 ES 2161361 T3 ES2161361 T3 ES 2161361T3 ES 96916138 T ES96916138 T ES 96916138T ES 96916138 T ES96916138 T ES 96916138T ES 2161361 T3 ES2161361 T3 ES 2161361T3
Authority
ES
Spain
Prior art keywords
antibacterial agents
oxides
acids
substituted
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96916138T
Other languages
English (en)
Inventor
Hubert Rast
Martin Scheer
Werner Hallenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2161361T3 publication Critical patent/ES2161361T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS AGENTES ANTIBACTERIANOS, ESPECIALMENTE AGENTES ADMINISTRADOS POR VIA ORAL, BASADOS EN N TROGENO, QUE ESTAN SUSTITUIDOS CON ACIDOS QUINOLONCARBOXILICOS O CON ACIDOS NAFTIRIDONCARBOXILICOS, ASI COMO NUEVAS SUSTANCIAS ACTIVAS Y SU PRODUCCION.
ES96916138T 1995-05-31 1996-05-20 N-oxidos como agentes antibacterianos. Expired - Lifetime ES2161361T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19519822A DE19519822A1 (de) 1995-05-31 1995-05-31 Neue antibakterielle Mittel

Publications (1)

Publication Number Publication Date
ES2161361T3 true ES2161361T3 (es) 2001-12-01

Family

ID=7763230

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96916138T Expired - Lifetime ES2161361T3 (es) 1995-05-31 1996-05-20 N-oxidos como agentes antibacterianos.

Country Status (23)

Country Link
US (1) US6114351A (es)
EP (1) EP0828715B1 (es)
JP (1) JP3868492B2 (es)
KR (1) KR100682746B1 (es)
CN (1) CN1214009C (es)
AR (2) AR003420A1 (es)
AT (1) ATE204256T1 (es)
AU (1) AU707628B2 (es)
BR (1) BR9608593A (es)
CA (1) CA2222552C (es)
CZ (1) CZ290675B6 (es)
DE (2) DE19519822A1 (es)
DK (1) DK0828715T3 (es)
ES (1) ES2161361T3 (es)
GR (1) GR3037063T3 (es)
HU (1) HUP9802076A3 (es)
NO (1) NO319510B1 (es)
NZ (1) NZ309074A (es)
PL (1) PL187322B1 (es)
SK (1) SK283994B6 (es)
TW (1) TW442290B (es)
WO (1) WO1996038417A1 (es)
ZA (1) ZA964414B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904108D0 (sv) * 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
US9625065B2 (en) 2004-09-03 2017-04-18 Loewenstein Medical Technology S.A. Plastics for medical technical devices
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3363711D1 (en) * 1982-03-31 1986-07-03 Sterling Drug Inc New quinolone compounds and preparation thereof
US5152984A (en) * 1990-11-20 1992-10-06 Dow Corning Corporation Hair fixatives

Also Published As

Publication number Publication date
CN1190958A (zh) 1998-08-19
HUP9802076A3 (en) 1999-03-01
KR100682746B1 (ko) 2008-11-18
KR19990022044A (ko) 1999-03-25
PL187322B1 (pl) 2004-06-30
BR9608593A (pt) 1999-01-05
SK160397A3 (en) 1998-05-06
NZ309074A (en) 1999-08-30
AR034452A2 (es) 2004-02-25
NO975464L (no) 1997-11-27
NO319510B1 (no) 2005-08-22
JP3868492B2 (ja) 2007-01-17
NO975464D0 (no) 1997-11-27
TW442290B (en) 2001-06-23
US6114351A (en) 2000-09-05
DK0828715T3 (da) 2001-10-08
HUP9802076A2 (hu) 1998-12-28
ATE204256T1 (de) 2001-09-15
EP0828715B1 (de) 2001-08-16
ZA964414B (en) 1996-12-09
GR3037063T3 (en) 2002-01-31
JPH11505855A (ja) 1999-05-25
AR003420A1 (es) 1998-08-05
CN1214009C (zh) 2005-08-10
CA2222552C (en) 2009-08-11
AU707628B2 (en) 1999-07-15
DE19519822A1 (de) 1996-12-05
WO1996038417A1 (de) 1996-12-05
SK283994B6 (sk) 2004-07-07
EP0828715A1 (de) 1998-03-18
AU5900596A (en) 1996-12-18
CZ374897A3 (cs) 1998-03-18
PL323622A1 (en) 1998-04-14
CZ290675B6 (cs) 2002-09-11
CA2222552A1 (en) 1996-12-05
DE59607503D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
ES2098140T3 (es) Liosferas que contienen gonadotropina.
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1999000066A (es) Formulaciones farmaceuticas
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
ES2162198T3 (es) Agentes estrogenos.
HN1998000036A (es) Compuesto de pirazina
BR0114059A (pt) Derivados de resorcinol
BR9803596A (pt) Derivados do resorcinol.
HN1998000175A (es) Imidazotriazininas
HN1999000221A (es) Moduladores de ccr5
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN2000000003A (es) Antibioticos cetolidos
NO974321D0 (no) Nodulisporsyrederivater
HN1998003689A (es) Azetidinas
HN1998000088A (es) Tratamiento de resistencia a la insulina
MX9300550A (es) Estructura de fibra absorbente.
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000045A (es) Composiciones farmaceuticas
ES2161361T3 (es) N-oxidos como agentes antibacterianos.
HN1998000193A (es) Compuestos de triazina
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
BR0308201A (pt) Derivados de quinolina
DK0931082T3 (da) Nodulisporinsyrederivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 828715

Country of ref document: ES